Insider Trades60 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 1, 2026 | Sell | STOK | Barry Ticho | CHIEF MEDICAL OFFICER | 7,228 | $32.66 | $1.8B | -27.77% | +144.32% | $236.1K | -11.49% | 10b5-1 | Trim |
| Jun 16, 2026 | Sell | STOK | Jonathan Allan | GENERAL COUNSEL & CORP SEC | 1,457 | $29.95 | $1.8B | -27.77% | +144.32% | $43.6K | -7.46% | 10b5-1 | Trim |
| Jun 1, 2026 | Sell | STOK | Barry Ticho | CHIEF MEDICAL OFFICER | 1,795 | $30.58 | $1.8B | -27.77% | +144.32% | $54.9K | -4.90% | 10b5-1 | Trim |
| May 1, 2026 | Sell | STOK | Barry Ticho | CHIEF MEDICAL OFFICER | 2,243 | $32.79 | $1.8B | -27.77% | +144.32% | $73.5K | -5.77% | 10b5-1 | Trim |
| Apr 1, 2026 | Sell | STOK | Barry Ticho | CHIEF MEDICAL OFFICER | 1,838 | $32.66 | $1.8B | -27.77% | +144.32% | $60.0K | -4.52% | 10b5-1 | Trim |
| Mar 20, 2026 | Sell | STOK | Jonathan Allan | GENERAL COUNSEL & CORP SEC | 9,293 | $33.69 | $1.8B | -27.77% | +144.32% | $313.0K | -18.97% | 10b5-1 | Trim |
| Mar 17, 2026 | Sell | STOK | Jason Hoitt | Chief Patient Officer | 3,712 | $32.14 | $1.8B | -27.77% | +144.32% | $119.3K | -6.20% | — | Trim |
| Mar 17, 2026 | Sell | STOK | Thomas Leggett | Chief Financial Officer | 4,578 | $32.14 | $1.8B | -27.77% | +144.32% | $147.1K | -7.46% | — | Trim |
| Mar 17, 2026 | Sell | STOK | Jonathan Allan | GENERAL COUNSEL & CORP SEC | 8,895 | $32.14 | $1.8B | -27.77% | +144.32% | $285.9K | -5.40% | — | Trim |
| Mar 17, 2026 | Sell | STOK | Barry Ticho | CHIEF MEDICAL OFFICER | 15,676 | $29.33 | $1.8B | -27.77% | +144.32% | $459.8K | -3.24% | 10b5-1 | Trim |
| Mar 10, 2026 | Sell | STOK | Arthur Tzianabos | Interim Executive Chair | 8,310 | $24.93 | $1.8B | -27.77% | +144.32% | $207.2K | -0.21% | 10b5-1 | Trim |
| Dec 8, 2025 | Sell | STOK | Jonathan Allan | GENERAL COUNSEL & CORP SEC | 3,978 | $32.28 | $1.8B | -27.77% | +144.32% | $128.4K | -13.12% | 10b5-1 | Trim |
| Dec 4, 2025 | Sell | STOK | Barry Ticho | CHIEF MEDICAL OFFICER | 5,358 | $31.19 | $1.8B | -27.77% | +144.32% | $167.1K | -5.69% | 10b5-1 | Trim |
| Dec 4, 2025 | Sell | STOK | Jonathan Allan | GENERAL COUNSEL & CORP SEC | 9,803 | $31.25 | $1.8B | -27.77% | +144.32% | $306.3K | -8.40% | 10b5-1 | Trim |
| Dec 2, 2025 | Sell | STOK | Barry Ticho | CHIEF MEDICAL OFFICER | 4,020 | $30.22 | $1.8B | -27.77% | +144.32% | $121.5K | -5.69% | — | Trim |
| Dec 2, 2025 | Sell | STOK | Jonathan Allan | GENERAL COUNSEL & CORP SEC | 4,576 | $30.22 | $1.8B | -27.77% | +144.32% | $138.3K | -5.09% | — | Trim |
| Nov 3, 2025 | Sell | STOK | Barry Ticho | CHIEF MEDICAL OFFICER | 5,931 | $25.72 | $1.8B | -27.77% | +144.32% | $152.6K | -15.75% | 10b5-1 | Trim |
| Oct 3, 2025 | Sell | STOK | Jonathan Allan | GENERAL COUNSEL & CORP SEC | 20,000 | $17.11 | $1.8B | -27.77% | +144.32% | $342.1K | +0.00% | 10b5-1 | Trim |
| Oct 1, 2025 | Sell | STOK | Barry Ticho | CHIEF MEDICAL OFFICER | 5,343 | $23.64 | $1.8B | -27.77% | +144.32% | $126.3K | -28.93% | 10b5-1 | Trim |
| Sep 2, 2025 | Sell | STOK | Barry Ticho | CHIEF MEDICAL OFFICER | 5,501 | $19.87 | $1.8B | -27.77% | +144.32% | $109.3K | -22.95% | 10b5-1 | Trim |
| Aug 29, 2025 | Sell | STOK | Jonathan Allan | GENERAL COUNSEL & CORP SEC | 32,117 | $16.05 | $1.8B | -27.77% | +144.32% | $515.5K | -7.36% | 10b5-1 | Trim |
| Aug 18, 2025 | Sell | STOK | Jonathan Allan | GENERAL COUNSEL & CORP SEC | 1,683 | $18.24 | $1.8B | -27.77% | +144.32% | $30.7K | -6.57% | — | Trim |
| Aug 18, 2025 | Sell | STOK | Barry Ticho | CHIEF MEDICAL OFFICER | 2,805 | $18.24 | $1.8B | -27.77% | +144.32% | $51.2K | -10.48% | — | Trim |
| Aug 13, 2025 | Sell | STOK | Jonathan Allan | GENERAL COUNSEL & CORP SEC | 13,712 | $15.00 | $1.8B | -27.77% | +144.32% | $205.7K | -41.12% | 10b5-1 | Trim |
| Aug 1, 2025 | Sell | STOK | Barry Ticho | CHIEF MEDICAL OFFICER | 4,504 | $12.82 | $1.8B | -27.77% | +144.32% | $57.7K | -21.17% | 10b5-1 | Trim |
| Jul 1, 2025 | Sell | STOK | Barry Ticho | CHIEF MEDICAL OFFICER | 4,503 | $11.63 | $1.8B | -27.77% | +144.32% | $52.4K | -17.47% | 10b5-1 | Trim |
| Jun 2, 2025 | Sell | STOK | Barry Ticho | CHIEF MEDICAL OFFICER | 8,216 | $10.02 | $1.8B | -27.77% | +144.32% | $82.3K | -12.40% | 10b5-1 | Trim |
| May 1, 2025 | Sell | STOK | Barry Ticho | CHIEF MEDICAL OFFICER | 26,631 | $10.02 | $1.8B | -27.77% | +144.32% | $267.0K | -22.68% | 10b5-1 | Trim |
| Mar 18, 2025 | Sell | STOK | Jonathan Allan | GENERAL COUNSEL & CORP SEC | 4,211 | $8.49 | $1.8B | -27.77% | +144.32% | $35.7K | -2.22% | — | Trim |
| Mar 18, 2025 | Sell | STOK | Barry Ticho | CHIEF MEDICAL OFFICER | 7,217 | $8.49 | $1.8B | -27.77% | +144.32% | $61.2K | -3.02% | — | Trim |
| Dec 30, 2024 | Buy | STOK | Edward M. Md Kaye | CEO | 35,000 | $0.60 | $1.8B | -27.77% | +144.32% | $21.0K | +5.56% | — | Trim |
| Dec 9, 2024 | Sell | STOK | Barry Ticho | CHIEF MEDICAL OFFICER | 2,586 | $12.99 | $1.8B | -27.77% | +144.32% | $33.6K | -5.46% | — | Trim |
| Dec 9, 2024 | Sell | STOK | Edward M. Md Kaye | CEO | 6,786 | $12.99 | $1.8B | -27.77% | +144.32% | $88.2K | -9.88% | — | Trim |
| Dec 9, 2024 | Sell | STOK | Jonathan Allan | GENERAL COUNSEL & CORP SEC | 13,666 | $13.61 | $1.8B | -27.77% | +144.32% | $186.0K | -23.49% | 10b5-1 | Trim |
| Dec 6, 2024 | Sell | STOK | Edward M. Md Kaye | CEO | 6,170 | $12.78 | $1.8B | -27.77% | +144.32% | $78.8K | -8.24% | — | Trim |
| Dec 6, 2024 | Sell | STOK | Jonathan Allan | GENERAL COUNSEL & CORP SEC | 9,696 | $12.78 | $1.8B | -27.77% | +144.32% | $123.9K | -21.62% | — | Trim |
| Dec 6, 2024 | Sell | STOK | Barry Ticho | CHIEF MEDICAL OFFICER | 13,945 | $12.78 | $1.8B | -27.77% | +144.32% | $178.2K | -22.76% | — | Trim |
| Dec 2, 2024 | Sell | STOK | Barry Ticho | CHIEF MEDICAL OFFICER | 20,000 | $6.33 | $1.8B | -27.77% | +144.32% | $126.7K | +0.00% | 10b5-1 | Trim |
| Nov 1, 2024 | Sell | STOK | Barry Ticho | CHIEF MEDICAL OFFICER | 20,000 | $6.64 | $1.8B | -27.77% | +144.32% | $132.8K | +0.00% | 10b5-1 | Trim |
| Oct 1, 2024 | Sell | STOK | Barry Ticho | CHIEF MEDICAL OFFICER | 20,000 | $6.33 | $1.8B | -27.77% | +144.32% | $126.6K | +0.00% | 10b5-1 | Trim |
| Sep 3, 2024 | Sell | STOK | Barry Ticho | CHIEF MEDICAL OFFICER | 20,000 | $7.77 | $1.8B | -27.77% | +144.32% | $155.5K | +0.00% | 10b5-1 | Trim |
| Aug 1, 2024 | Sell | STOK | Barry Ticho | CHIEF MEDICAL OFFICER | 20,000 | $7.59 | $1.8B | -27.77% | +144.32% | $151.8K | +0.00% | 10b5-1 | Trim |
| Jul 2, 2024 | Sell | STOK | Huw M. Nash | Chief Business Officer | 2,500 | $13.11 | $1.8B | -27.77% | +144.32% | $32.8K | -98.70% | 10b5-1 | Trim |
| Jul 1, 2024 | Sell | STOK | Barry Ticho | CHIEF MEDICAL OFFICER | 20,000 | $7.17 | $1.8B | -27.77% | +144.32% | $143.5K | +0.00% | 10b5-1 | Trim |
| Jun 3, 2024 | Sell | STOK | Barry Ticho | CHIEF MEDICAL OFFICER | 20,000 | $7.91 | $1.8B | -27.77% | +144.32% | $158.2K | +0.00% | 10b5-1 | Trim |
| May 20, 2024 | Sell | STOK | Jonathan Allan | GENERAL COUNSEL & CORP SEC | 17,198 | $11.05 | $1.8B | -27.77% | +144.32% | $190.1K | +0.00% | 10b5-1 | Trim |
| May 20, 2024 | Sell | STOK | Edward M. Md Kaye | CEO | 42,350 | $15.43 | $1.8B | -27.77% | +144.32% | $653.5K | -42.77% | 10b5-1 | Trim |
| May 20, 2024 | Sell | STOK | Huw M. Nash | COO & CBO | 100,000 | $7.89 | $1.8B | -27.77% | +144.32% | $789.5K | +0.00% | 10b5-1 | Trim |
| May 1, 2024 | Sell | STOK | Barry Ticho | CHIEF MEDICAL OFFICER | 20,000 | $5.98 | $1.8B | -27.77% | +144.32% | $119.7K | +0.00% | 10b5-1 | Trim |
| Apr 1, 2024 | Sell | STOK | Barry Ticho | CHIEF MEDICAL OFFICER | 9,868 | $12.66 | $1.8B | -27.77% | +144.32% | $124.9K | -8.69% | 10b5-1 | Trim |
| Apr 1, 2024 | Sell | STOK | Huw M. Nash | COO & CBO | 111,329 | $7.47 | $1.8B | -27.77% | +144.32% | $831.2K | -6.70% | 10b5-1 | Trim |
| Mar 28, 2024 | Sell | STOK | Jonathan Allan | GENERAL COUNSEL & CORP SEC | 5,126 | $13.20 | $1.8B | -27.77% | +144.32% | $67.7K | -49.18% | 10b5-1 | Trim |
| Mar 19, 2024 | Sell | STOK | Jonathan Allan | GENERAL COUNSEL & CORP SEC | 2,349 | $6.10 | $1.8B | -27.77% | +144.32% | $14.3K | -7.23% | — | Trim |
| Mar 19, 2024 | Sell | STOK | Huw M. Nash | COO & CBO | 4,116 | $6.10 | $1.8B | -27.77% | +144.32% | $25.1K | -7.52% | — | Trim |
| Mar 19, 2024 | Sell | STOK | Barry Ticho | CHIEF MEDICAL OFFICER | 4,116 | $6.10 | $1.8B | -27.77% | +144.32% | $25.1K | -7.50% | — | Trim |
| Mar 19, 2024 | Sell | STOK | Stephen J Tulipano | CFO | 4,116 | $6.10 | $1.8B | -27.77% | +144.32% | $25.1K | -6.42% | — | Trim |
| Mar 19, 2024 | Sell | STOK | Edward M. Md Kaye | CEO | 11,150 | $6.10 | $1.8B | -27.77% | +144.32% | $68.0K | -5.96% | — | Trim |
| Mar 1, 2024 | Sell | STOK | Barry Ticho | CHIEF MEDICAL OFFICER | 15,504 | $5.21 | $1.8B | -27.77% | +144.32% | $80.8K | -4.50% | 10b5-1 | Trim |
| Feb 1, 2024 | Sell | STOK | Barry Ticho | CHIEF MEDICAL OFFICER | 10,000 | $4.80 | $1.8B | -27.77% | +144.32% | $48.0K | -58.89% | 10b5-1 | Trim |
| Jan 2, 2024 | Sell | STOK | Barry Ticho | Chief Medical Officer | 10,000 | $5.74 | $1.8B | -27.77% | +144.32% | $57.4K | -37.06% | 10b5-1 | Trim |